Native vs. ribosome‐crosslinked collagen membranes for periodontal regeneration: A randomized clinical trial
Journal of Periodontal Research · 2025
DOI: 10.1111/jre.13321 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontal Research, 2025. Verfasst von Yiwei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Collagen, Guided Tissue Regeneration, Periodontal, Membranes, Artificial, Periodontitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovative Research Team of High-level Local University in Shanghai, NIBEC Jincheon Factory CO. Ltd., Korea.
Abstract (Originalsprache)
Aim
To evaluate whether the ribosome‐crosslinked collagen membrane (RCCM) is non‐inferior to the natural collagen membrane (NCM) used in regeneration surgery in terms of clinical attachment level (CAL) gain at 6 months.
Methods
Eighty patients diagnosed as generalized periodontitis presenting with isolated infrabony defect (≥4 mm deep) were enrolled and randomized to receive regenerative surgery, either with NCM or RCCM, both combined with deproteinized bovine bone mineral (DBBM). CAL, pocket probing depth (PPD), and gingival recession (GR) were recorded at baseline, 3, and 6 months postoperatively. Periapical radiographs were taken at baseline, immediately, and 6 months after surgery. Early wound healing index (EHI) and patients' responses were recorded at 2 weeks postoperatively.
Results
At 6 months post‐surgery, the mean CAL gain was 3.1 ± 1.5 mm in the NCM group and 2.9 ± 1.5 mm in the RCCM group, while the mean PPD was 4.3 ± 1.1 mm in the NCM group and 4.2 ± 1.0 mm in the RCCM group. Both groups demonstrated a statistically significant improvement from the baseline ( p < .01). RCCM was non‐inferior to NCM concerning the primary outcome (CAL gain at 6 months). The GR at 6 months postoperatively was 1.3 ± 1.2 and 1.2 ± 1.1 mm, which showed no difference compared with baseline. At 6 months follow‐up, the radiographic linear bone fill (RLBF) was 6.5 ± 2.8 and 5.5 ± 2.6 mm ( p > .05), while the bone fill percentage (BF%) was 102.3 ± 53.5% and 92.3 ± 40.1% ( p > .05), in the NCM and RCCM groups, respectively. There was no significant difference in EHI and postoperative responses between two groups.
Conclusion
RCCM + DBBM resulted in no‐inferior clinical and radiographic outcomes to NCM + DBBM for the treatment of isolated infrabony defect in 6 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- College of Stomatology, Shanghai Jiao Tong University, Shanghai, China.
- National Center for Stomatology, Shanghai, China.
- National Clinical Research Center for Oral Diseases, Shanghai, China.
- Shanghai Key Laboratory of Stomatology, Shanghai, China.
- Shanghai Research Institute of Stomatology, Shanghai, China.
ORCID-Profile: Rong Shu, Zhikai Lin
Förderung
- National Natural Science Foundation of China
- Innovative Research Team of High-level Local University in Shanghai
- NIBEC Jincheon Factory CO. Ltd., Korea
Zitieren
APA
Wang, Y., Xia, Y., Qian, J., Xie, Y., Shu, R., & Lin, Z. (2025). Native vs. ribosome‐crosslinked collagen membranes for periodontal regeneration: A randomized clinical trial. Journal of Periodontal Research. https://doi.org/10.1111/jre.13321
Vancouver
Wang Y, Xia Y, Qian J, Xie Y, Shu R, Lin Z. Native vs. ribosome‐crosslinked collagen membranes for periodontal regeneration: A randomized clinical trial. Journal of Periodontal Research. 2025. doi:10.1111/jre.13321
BibTeX
@article{Wang2025,
author = {Wang, Yiwei and Xia, Yiru and Qian, Jielei and Xie, Yufeng and Shu, Rong and Lin, Zhikai},
title = {Native vs. ribosome‐crosslinked collagen membranes for periodontal regeneration: A randomized clinical trial},
journal = {Journal of Periodontal Research},
year = {2025},
doi = {10.1111/jre.13321}
}
EUVIMED